PUT - SPRINTER OPEN END - BIOGEN IDEC | Market Closed - Deutsche Boerse AG 13:53:01 2024-07-05 EDT | ||
| 15.91 EUR | -0.50% |
|
| Current month | +1.98% | ||
| 1 month | +5.20% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
BIOGEN INC.
Latest news about BIOGEN INC.
More news
| Date | Price | Change |
|---|---|---|
| 24-07-05 | 15.91 | -0.50% |
| 24-07-04 | 15.99 | -0.62% |
| 24-07-03 | 16.09 | +0.37% |
| 24-07-02 | 16.03 | +2.76% |
| 24-07-01 | 15.6 | -0.51% |
Delayed Quote Deutsche Boerse AG
Last update July 05, 2024 at 01:53 pm
More quotesStatic data
| Product type | Knock-Out without Stop Loss |
|---|---|
| Buy / Sell | PUT |
| Underlying | BIOGEN INC. |
| Issuer | 
Vontobel
|
| WKN | VQ8QB8 |
| ISIN | DE000VQ8QB81 |
| Date issued | 2021-06-16 |
| Strike | 395.8 $ |
| Maturity | Unlimited |
| Parity | 10 : 1 |
| Emission price | 0.4 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 20.13 € |
|---|---|
| Lowest since issue | 0.85 € |
Company Profile
Biogen Inc. is one of the world's leaders in the design, manufacturing, and marketing of therapeutic products. Net sales break down by source of income as follows:
- sales of medicines (73,7%): for treating multiple sclerosis, chronic psoriasis in adults, rheumatoid arthritis, cancers, etc.;
- royalties (17,2%) ;
- other (9,1%): primarily revenues from partnership agreements.
Sector
-
Consensus: Biogen Inc.
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
35
Last Close Price
224.6
USD
Average target price
283.2
USD
Spread / Average Target
+26.06%
- Stock Market
- Certificates
- Certificat
